CordenPharma aumenta la capacità di riempimento e finitura asettici fino a 500 milioni di unità sterili iniettabili all'anno

Positive

AI Analysis

Summary

CordenPharma is investing €80 million over multiple years in a new facility and additional aseptic fill-finish lines to increase sterile injectable manufacturing capacity to 500 million units annually.

Importance:5/10

Sentiment:

0.60

CDMOmanufacturingcapacity expansionaseptic fill-finishinjectablecapital investment

Related Companies

$BSLN.SW

Read the original article

Published by PR Newswire Biotech on September 11, 2026 2:54 AM

Read Original